bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE marking of its innovative and fully-automated assays to diagnose dengue infection: VIDAS^® DENGUE NS1 Ag VIDAS^® Anti-DENGUE IgM VIDAS^® Anti-DENGUE IgG

Marcy l’Étoile (France) – bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, its subsidiary specialized in molecular syndromic infectious disease testing, has received U.S. Food and Drug Administration (FDA) De Novo authorization for the BIOFIRE^® RP2.1 Panel. 

Marcy l’Etoile, Francia – 3 Febbraio, 2021 – bioMérieux, leader globale nella diagnostica in vitro comunica la marcatura CE dell’innovativo test  NEPHROCHECK® in grado di individuare lo stress renale nei pazienti a rischio di danno renale acuto (AKI).

Marcy l’Etoile, France – November 16, 2020 – bioMérieux, a world leader in the field of in vitro diagnostics, has announced the expansion of its ARGENE^® range for the detection of SARS-CoV-2. As a complement to nasopharyngeal swab specimens, the singleplex SARS-CoV-2 R-GENE^® real-time PCR test may now be used on saliva and oropharyngeal (throat) swab specimens for the detection of the virus that causes COVID-19. This development helps optimize laboratory workflows.